Comments on: Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial

Comments on: Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial https://9krapalm.com/insilico-and-taigen-achieve-milestone-in-collaboration-out-licensed-ckd-anemia-candidate-ism4808-completes-first-human-enrollment-and-dosing-in-phase-i-clinical-trial/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Fri, 06 Mar 2026 11:25:23 +0000 hourly 1 https://wordpress.org/?v=7.0